Photograph of a female CSL in a laboratory setting. This image is the hero of CSL's 2026 Impact Report document.

Our Impact

Our Impact in 2026

How do you measure a year? By the numbers.
CSL's impact can be seen in the patients treated, lives protected from influenza, partnerships formed and scientific questions explored.

Behind the Numbers
Pictured of CSL Patient Stacy sitting at a table and smiling.

A Nurse Turned Patient:
Stacy's Story

For years, Stacy had frequent infections without explanation.
Today, she's focused on staying active and being a Mom.

 

Learn More
A headshot style photo of CSL Patient, Julie who is smiling.

HAE No Longer Rules Julie's Life

Hereditary angioedema (HAE) is a dangerous condition that causes swelling that can be life-threatening. Julie says finding the right treatment gave her the freedom to travel far from home and enjoy retirement.

Learn More
Picutre of two male scientists in a laboratory looking at medical equipment

Focused Science = Progress for Patients & Public Health

We operated 41 clinical trials, achieved 60 new product registrations and added 23 new indications for existing products.

 

Learn More
A photo of CSL patient 'Tim' who is smiling while sitting at a table

Building Stronger Health Systems and Patient Communities

We improved access to critical medicines and vaccines while supporting the vibrant communities that bring people together.

Learn More

Impact Report Highlights

  • Stacy - 1600x1000px
    8.3m

    patients treated with plasma-derived and recombinant therapies

  • Roberta 1600x900
    114m

    doses of seasonal influenza vaccine distributed globally

  • US$28m

    contributed to support patient communities

  • 83

    major regulatory approvals comprising 60 new product registrations and 23 new indications across all five of our therapeutic areas.

  • 2026 Impact Report Image 1600x900
    US$12.1m

    contributed to science and innovation to advance knowledge, research and careers in biomedicine

  • Clinical trials
    41

    clinical trials in operation across all therapeutic areas. Of those, nine trials had a first patient enrolled in the trial during this fiscal year

  • CSL Plasma Center 1600x900
    ~US$6m

    in economic activity per donor centre

  • 2026 Impact Report Cycling 1600x900
    US$2.1m

    in contributions to local communities

  • 120+

    countries make use of CSL's lifesaving vaccines and medicines

Read More on Related Topics

CSL's Annual Report 2024-25 Cover Image
CSL Statement on Modern Slavery 2025
CSL Tax Transparency Report 2025
Image of the Aboriginal Artwork which appears on the front cover of CSL's Reflection Reconciliation Action Plan document. Artwork provided by Simone Thomson in collaboration with Dreamtime Art Creative Consultancy.

CSL Impact Report Archive